Denmark’s medical cannabis pilot program notched another positive quarter, but the number of unique consumers remains well below the trial’s peak seen one year ago. The Danish market is struggling to demonstrate how businesses need to factor market ebbs and flows into their projections, rather than counting on consistent, perpetual growth. The pilot program started in January 2018 and enjoyed rapid growth until mid-2019, when about 1,000 patients were receiving 1,800 prescriptions per quarter. Also, the number of patients sharply declined in the second half of 2019. Currently, the experiment has had 2,550 patients so far.

Marijuana Business Daily, 10/29/2020 09:21:17

Open article: